Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1978-10-16
1980-04-08
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
A01N 900, A01N 922
Patent
active
041973011
ABSTRACT:
An ophthalmic composition comprising Prazosin or a pharmaceutically acceptable salt thereof and a topically administrable ophthalmic pharmaceutical carrier. The foregoing composition is useful in lowering intraocular pressure in the eye. Reduction of intraocular pressure is of particular importance in the treatment of glaucoma, a disease characterized by elevated intraocular pressure.
REFERENCES:
patent: 3511836 (1970-05-01), Hess
patent: 3517005 (1970-06-01), Cronin et al.
patent: 3920636 (1975-11-01), Takahashi et al.
patent: 4001237 (1977-01-01), Partyka et al.
patent: 4026894 (1977-05-01), Winn et al.
patent: 4092315 (1978-05-01), Bianco
patent: 4112097 (1978-05-01), Winn et al.
The Pharmacological Basis of Therapeutic, pp. 559-563, (1966).
Chem. Abst. 77:(775w) (1972), Pecori--Giraldi et al.
Murray David L.
Smith Barry R.
Allergan Pharmaceuticals, Inc.
Robinson Douglas W.
Voet Martin A.
LandOfFree
Topical ophthalmic use of Prazosin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Topical ophthalmic use of Prazosin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical ophthalmic use of Prazosin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-973696